Dermira, Inc.
Dermira is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions. We are committed to understanding the needs of both patients and physicians and using our insight to identify and develop leading-edge medical dermatology programs. Our product pipeline includes three Phase 3 product candidates that could have a profound impact on the lives of patients.